Shareholdings
| Concept |
2024-03-01 to 2025-02-28 |
As at 2025-02-28 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues | — |
15
xbrli:pure
|
| Carrying amount | — |
6,556,000,000
JPY
|
| Number of issues whose number of shares increased |
1
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
100,000,000
JPY
|
— |
| Reason for increase in number of shares |
医薬品開発における関係強化のための取得。
|
— |
| Number of issues whose number of shares decreased |
xbrli:pure
|
— |
| Total sale amount for decreased shares |
JPY
|
— |
| Shares other than those not listed | ||
| Number of issues | — |
62
xbrli:pure
|
| Carrying amount | — |
45,154,000,000
JPY
|
| Number of issues whose number of shares increased |
4
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
15,000,000
JPY
|
— |
| Reason for increase in number of shares |
取引先持株会を通じた取得。
|
— |
| Number of issues whose number of shares decreased |
9
xbrli:pure
|
— |
| Total sale amount for decreased shares |
7,711,000,000
JPY
|
— |